As Big Tech and major retail firms move into healthcare they bring promises of convenience and innovation they claim will benefit consumers — but the move also raises questions about the ever-growing power and influence of such firms and their real motivation for getting into healthcare.
U.S. stocks edged lower on Thursday on worries about the raging conflict in Ukraine and the outlook for U.S. interest rate hikes, putting the main indexes on course for their worst quarter since the pandemic crash in 2020.
Pesident Joe Biden’s 40-year-high inflation will cost American households on average an extra $5,200 in 2022, or $433 per month, according to Bloomberg.
In an exclusive interview with BlazeTV host Glenn Beck, former President Donald Trump discussed his lawsuit against Hillary Clinton, the Democratic National Committee, and others who he says colluded to defeat his 2016 presidential campaign and sabotage his presidency.
Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
While Republican Pennsylvania Senate candidate Dr. Mehmet Oz has billed himself as a staunch opponent of big corporations, his ties to major technology and pharmaceutical corporations complicate his campaign rhetoric.
In February 2020, the Trump administration drafted a policy document—stamped “not for public distribution or release” and indeed kept from public view for months—that would guide decision makers at every level of government and every sector of the economy in dealing with a new virus that came to be known by the scientific shorthand “Covid-19.”
Despite the pressure from climate change activists in the federal government and the private sector to cut back on drilling for oil, the price for fossil fuels is the highest since 2014.
